Dupont Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,469
| Closed | -$158K | – | 1733 |
|
|
2022
Q2 | $158K | Sell |
11,469
-16,810
| -59% | -$232K | 0.01% | 1045 |
|
|
2022
Q1 | $460K | Sell |
28,279
-2,501
| -8% | -$40.7K | 0.02% | 809 |
|
|
2021
Q4 | $501K | Buy |
30,780
+9,846
| +47% | +$160K | 0.02% | 778 |
|
|
2021
Q3 | $311K | Sell |
20,934
-2,960
| -12% | -$44K | 0.01% | 1059 |
|
|
2021
Q2 | $477K | Hold |
23,894
| – | – | 0.01% | 1026 |
|
|
2021
Q1 | $551K | Buy |
23,894
+16,211
| +211% | +$374K | 0.01% | 869 |
|
|
2020
Q4 | $190K | Sell |
7,683
-574
| -7% | -$14.2K | ﹤0.01% | 1144 |
|
|
2020
Q3 | $342K | Buy |
8,257
+2,588
| +46% | +$107K | 0.01% | 928 |
|
|
2020
Q2 | $272K | Buy |
5,669
+2,165
| +62% | +$104K | 0.01% | 1009 |
|
|
2020
Q1 | $221K | Buy |
+3,504
| New | +$221K | 0.01% | 983 |
|